A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
News|Articles|August 27, 2026
FAQ: What you need to know about ACOG's new maternal immunization schedule
Author(s)Contemporary OB/GYN Staff
Fact checked by: Joshua Fitch, Senior Editor
Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.
Advertisement
Advertisement
Earlier this summer, on June 10, 2026, the American College of Obstetricians & Gynecologists (ACOG) released its
Related to this article
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Amber Watters, MD, MS, explains that emergent delivery after external cephalic version is exceedingly rare and fits within existing protocols, and outlines how to build a version program.
Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.
Kevin Ault, MD, FACOG, emphasizes that obstetric clinicians are patients' most trusted vaccine information source, making maternal COVID-19 counseling a high-value opportunity.
FDA granted BTD to certolizumab pegol for preventing adverse pregnancy outcomes in women with antiphospholipid syndrome.
Amber Watters, MD, MS, explains how the ASA's statement encourages obstetric units to integrate neuraxial anesthesia into a formal external cephalic version process.
Advertisement
Advertisement